Vitamin D for pulmonary arterial hypertension
Part of Hormones & metabolism, Lungs & breathing clinical trials.
This trial tests whether giving vitamin D to people with pulmonary arterial hypertension (high blood pressure in the lungs) who have very low vitamin D levels can improve their condition. It aims to see if restoring vitamin D helps with symptoms and overall stability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a type of pulmonary arterial hypertension (PAH) that is either idiopathic, hereditary, caused by drugs or toxins, or linked to connective tissue disease.
- Your PAH has been stable on your current medications for at least 6 weeks.
- Your vitamin D level in the blood is very low — 12 ng/ml or lower.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study (if applicable).
- You are not taking digoxin (a heart medication) as an active treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the cells lining your blood vessels and the pressure in your lungs affect pulmonary arterial hypertension (PAH). It tests a new drug called XBD173 to see if it can help improve your condition.
This study looks at stored blood samples from people with different types of pulmonary hypertension to see if vitamin D and parathyroid hormone levels can predict how the disease progresses. It might help doctors better understand the condition and guide future treatments.
This trial tests whether taking vitamin D supplements can improve symptoms and quality of life for people with heart failure. It may help reduce inflammation and support heart function.
This trial tests an experimental drug called HS235 for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. It aims to see if the drug can help improve symptoms and exercise ability.
This trial tests whether taking sildenafil (a medicine that helps relax blood vessels) on demand, compared to a sugar candy placebo, can improve exercise capacity in people with pulmonary arterial hypertension (PAH). Participating may help you exercise more easily and contribute to better treatment options.
This trial tests an investigational drug called NS-863 for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. The study aims to see if the drug can improve symptoms and exercise ability.
Hear when a new Pulmonary Artery Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.